Focus: Cancer Channel Featured Story TOP

Filters close
Newswise: Cancer.jpg
Released: 27-Feb-2020 12:20 PM EST
Cancer survival disparities in minority children, adolescents greater for more treatable cancers
Washington University in St. Louis

Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger disparities in survival for more treatable cancers, finds a new study from the Brown School at Washington University in St. Louis.“The results suggest that there are modifiable racial and ethnic disparities in childhood cancer survival,” said Kim Johnson, associate professor and senior author of “Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability,” published Feb.

Released: 22-Jan-2020 9:00 AM EST
Decline in Late Stage Cancer Diagnoses After Health Reform Law
Health Sciences at the University of Pittsburgh

Advanced stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research.

22-Nov-2019 6:00 AM EST
Hibernating Mammals Arouse Hope for Genetic Solutions to Obesity, Metabolic Diseases
University of Utah Health

University of Utah Health scientists say they have detected new genetic clues about hibernation that could lead to better understanding and treatment of obesity and metabolic disorders that afflict millions of people worldwide.

Released: 4-Nov-2019 11:05 AM EST
Fluorescent probes offer fuller view of drug delivery in cells
Cornell University

Selecting the most effective molecules for drug delivery is often a trial-and-error process, but Cornell engineers are providing some precision thanks to a technique that reveals the performance of those molecules inside living cells.

Newswise: Using Artificial Intelligence to Predict Risk of Thyroid Cancer on Ultrasound
23-Oct-2019 2:40 PM EDT
Using Artificial Intelligence to Predict Risk of Thyroid Cancer on Ultrasound
Thomas Jefferson University

New study uses machine learning on ultrasound images of thyroid nodules to predict risk of malignancy

Newswise: Creatine powers T cells’ fight against cancer
Released: 18-Oct-2019 12:05 PM EDT
Creatine powers T cells’ fight against cancer
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of killer T cells, the foot soldiers of the immune system.

Released: 16-Oct-2019 8:50 AM EDT
Expert Panel: Cancer Treatment Plans Should Include Tailored Exercise Prescriptions
American College of Sports Medicine (ACSM)

New guidance from exercise oncology experts recommend systematic use of an “exercise prescription” by health care workers and fitness professionals in designing and delivering exercise programs that aim to lower the risk of developing certain cancers and best meet the needs, preferences and abilities of people with cancer. 17 organizations reviewed the latest scientific evidence and offer recommendations about the benefits of exercise for prevention, treatment, recovery and improved survival.

Newswise: Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study
9-Oct-2019 4:05 PM EDT
Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study
National Comprehensive Cancer Network® (NCCN®)

Patients pay less out-of-pocket for metastatic breast cancer (MBC) treatment that aligns with recommendations from NCCN Guidelines, according to a new study from the O’Neal Comprehensive Cancer Center at University of Alabama at Birmingham (UAB), published in the October 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network.

Released: 17-Sep-2019 8:00 AM EDT
First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles
Children's Hospital Los Angeles

A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.

Newswise: Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions
Released: 12-Sep-2019 9:00 AM EDT
Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions
Johns Hopkins Medicine

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings. Now, researchers at Johns Hopkins Medicine have improved on this protein and shown that it selectively kills cells that cause the hardening of skin associated with scleroderma, effectively reversing the condition in mice genetically engineered to mimic the disease. A report on these results was published earlier this year in Nature Communications.


Showing results

110 of 10

close
0.39227